Terapia Celular Adoptiva
![Foto de Terapia Celular Adoptiva](/img/uploaded/a9b86179c93719586056a50e4d0a30c4.jpg)
![Foto de Centro Nacional de Biotecnología](/img/noimage_org.png)
Centro Nacional de Biotecnología
Madrid, EspañaPublications in collaboration with researchers from Centro Nacional de Biotecnología (2)
2020
-
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens
Journal for immunotherapy of cancer, Vol. 8, Núm. 1
2018
-
The Toll like receptor 4 ligand cold-inducible RNA-binding protein as vaccination platform against cancer
OncoImmunology, Vol. 7, Núm. 4